Hanyu Taketo, Izumi Takashi, Tanei Takafumi, Nishihori Masahiro, Goto Shunsaku, Araki Yoshio, Yokoyama Kinya, Miyachi Shigeru, Saito Ryuta
Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Neurosurgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Nagoya J Med Sci. 2024 Nov;86(4):596-607. doi: 10.18999/nagjms.86.4.596.
The anatomical characteristics of middle cerebral artery aneurysms make endovascular treatment difficult. This study evaluated the efficacy and safety of endovascular treatment of unruptured middle cerebral artery aneurysm in preventing rupture. A retrospective review of patients who underwent coil embolization for unruptured middle cerebral artery aneurysm between 2006 and 2022 at Nagoya University Hospital with at least 12 months followed up was conducted. Imaging and clinical outcomes were described using the Raymond classification and the modified Rankin Scale, respectively. Good imaging outcome was defined as complete occlusion or neck remnant and clinical outcome as modified Rankin Scale score of 0-2. Patients were divided into initial and recurrent group based on the number of treatments, pre- and post-stent groups based on when stents became available in Japan. A total of 77 patients (80 with aneurysms) were included in the final analysis. Their average age was 60.3 years, and their average follow-up period was 38 months. Favorable clinical outcomes were achieved for 96.2% among 66 (97.0%) initial and 11 (91.7%) recurrent aneurysms. Furthermore, good imaging outcomes were obtained in 90.0 %, and 5% had permanent symptomatic ischemic complications. The pre-stent group had a significantly higher proportion of patients with narrow-neck aneurysms than the post-stent group. There were no significant differences in terms of imaging and clinical outcomes or complication rates. The present study demonstrated that endovascular treatment of unruptured middle cerebral artery aneurysm was safe and effective in preventing rupture. The wide-neck aneurysm was also well embolized by using adjunctive technique.
大脑中动脉动脉瘤的解剖学特征使血管内治疗具有挑战性。本研究评估了未破裂大脑中动脉动脉瘤血管内治疗预防破裂的有效性和安全性。对2006年至2022年在名古屋大学医院接受未破裂大脑中动脉动脉瘤弹簧圈栓塞治疗且随访至少12个月的患者进行了回顾性研究。分别使用雷蒙德分类和改良Rankin量表描述影像学和临床结果。良好的影像学结果定义为完全闭塞或颈部残留,临床结果定义为改良Rankin量表评分为0-2。根据治疗次数将患者分为初次治疗组和复发组,根据日本支架可用时间分为支架置入前组和支架置入后组。最终分析共纳入77例患者(80个动脉瘤)。他们的平均年龄为60.3岁,平均随访期为38个月。66个(97.0%)初次治疗的动脉瘤和11个(91.7%)复发的动脉瘤中,96.2%取得了良好的临床结果。此外,90.0%获得了良好的影像学结果,5%发生了永久性症状性缺血并发症。支架置入前组窄颈动脉瘤患者的比例显著高于支架置入后组。在影像学和临床结果或并发症发生率方面没有显著差异。本研究表明,未破裂大脑中动脉动脉瘤的血管内治疗在预防破裂方面是安全有效的。使用辅助技术也能很好地栓塞宽颈动脉瘤。